- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 14 Aug 2025
- latest of these filings; the earliest 6 Aug 2025
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 17 listed it in both
- Shares listed
- 26,983,390
- combined, among listed positions
- Reported value
- $11.0bn
- combined, at the quarter end
Among the 95 comparable managers: 14 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing CHTR in Q2 2025
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Bridgewater Associates LPexisting position · 436,341 shares now+221,796
- Steadfast Capital Management LPexisting position · 370,966 shares now+217,600
- Arrowstreet Capital LPexisting position · 1,575,818 shares now+209,869
- T. Rowe Price Associates Incexisting position · 1,479,806 shares now+196,491
- Holocene Advisors LPexisting position · 367,607 shares now+152,960
Reductions
- Berkshire Hathaway Incexisting position · 1,060,882 shares now-923,377
- Citadel Advisors LLCexisting position · 958,424 shares now-637,603
- Harris Associates LPexisting position · 3,672,367 shares now-469,692
- Dodge & Coxexisting position · 11,126,486 shares now-379,634
- First Eagle Investment Management LLCexisting position · 754,426 shares now-14,485
New positions and exits
New (2)
Exited (2)
- Capital Research Global Investorswas $600m
- PDT Partners LLCwas $3.4m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2016 | 44 | $21.1bn | n.a. | n.a. |
| Q3 2016 | 36 | $23.3bn | n.a. | n.a. |
| Q4 2016 | 36 | $23.4bn | n.a. | n.a. |
| Q1 2017 | 40 | $26.8bn | n.a. | n.a. |
| Q2 2017 | 34 | $25.9bn | n.a. | n.a. |
| Q3 2017 | 38 | $24.9bn | n.a. | n.a. |
| Q4 2017 | 32 | $20.7bn | n.a. | n.a. |
| Q1 2018 | 30 | $18.4bn | n.a. | n.a. |
| Q2 2018 | 17 | $18.1bn | n.a. | n.a. |
| Q3 2018 | 23 | $20.0bn | n.a. | n.a. |
| Q4 2018 | 19 | $16.3bn | n.a. | n.a. |
| Q1 2019 | 24 | $18.7bn | n.a. | n.a. |
| Q2 2019 | 23 | $21.1bn | n.a. | n.a. |
| Q3 2019 | 27 | $21.5bn | n.a. | n.a. |
| Q4 2019 | 28 | $22.9bn | n.a. | n.a. |
| Q1 2020 | 38 | $19.1bn | n.a. | n.a. |
| Q2 2020 | 34 | $21.6bn | n.a. | n.a. |
| Q3 2020 | 35 | $25.6bn | n.a. | n.a. |
| Q4 2020 | 33 | $25.7bn | n.a. | n.a. |
| Q1 2021 | 30 | $24.5bn | n.a. | n.a. |
| Q2 2021 | 27 | $28.7bn | n.a. | n.a. |
| Q3 2021 | 29 | $28.0bn | n.a. | n.a. |
| Q4 2021 | 26 | $23.2bn | n.a. | n.a. |
| Q1 2022 | 29 | $17.8bn | n.a. | n.a. |
| Q2 2022 | 29 | $14.9bn | n.a. | n.a. |
| Q3 2022 | 25 | $8.8bn | n.a. | n.a. |
| Q4 2022 | 27 | $10.5bn | n.a. | n.a. |
| Q1 2023 | 23 | $10.2bn | n.a. | n.a. |
| Q2 2023 | 23 | $10.6bn | n.a. | n.a. |
| Q3 2023 | 20 | $13.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $11.0bn | 11 | 11 |
| Q1 2024 | 12 | $7.3bn | 7 | 11 |
| Q2 2024 | 17 | $8.4bn | 14 | 4 |
| Q3 2024 | 23 | $8.8bn | 17 | 8 |
| Q4 2024 | 24 | $9.4bn | 13 | 12 |
| Q1 2025 | 26 | $11.0bn | 19 | 9 |
| Q2 2025 | 20 | $11.0bn | 14 | 8 |
| Q3 2025 | 16 | $6.9bn | 7 | 9 |
| Q4 2025 | 11 | $7.3bn | 21 | 20 |
| Q1 2026 | 13 | $7.4bn | 19 | 20 |
| Q2 2026 | 13 | $3.8bn | 25 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CHTR and NFLX →CHTR and TMUS →CHTR and CMCSA →Choose a stock to compare with CHTR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CHTR, latest filings →Back to the 13F Explorer →